Frameworks for Digital Advertising
Standards in Medicine.

Spain · Advertising framework

Podcast advertising and host-read promotions for prescription medicines in Spain

General market orientation, not campaign clearance. Research scope and dates

Product and service rules

Public medicine eligibility excludes the ordinary Rx route

Legal requirement — paraphrased

Article 80 public-advertising eligibility requires, among other conditions, use without a doctor’s diagnosis, prescription or monitoring, absence of public funding and no controlled-substance restriction. Specific authorised vaccination campaigns have a distinct exception. Do not treat this as permission for routine public Rx promotion.

Sources: RDL 1/2015: guarantees and rational use of medicines and health products

Channel rules

Check the complete consumer-facing message

Regulator guidance

The EU consumer-protection framework addresses misleading actions and omissions, including an overall deceptive presentation and undisclosed commercial intent. Review benefits, risks, qualifications and prices as a whole under the national implementing law. Space limits do not provide an automatic exemption from material information requirements.

Sources: EU Unfair Commercial Practices Directive 2005/29/EC

Identify the advertisement and advertiser

Regulator guidance

LSSI guidance requires online commercial communications to be recognisable as advertising and identify the advertiser. This applies alongside health-sector restrictions; a label does not authorise a prohibited health claim.

Sources: LSSI: Publicidad en Internet

Review personal data separately from the advertisement

Legal requirement — paraphrased

Identify an Article 6 basis for personal-data processing and an applicable Article 9 condition for health data. Provide appropriate transparency and honour the right to object to direct marketing. Permission to deliver healthcare does not automatically authorise advertising use of patient data; electronic contact and trackers also need their own local review.

Sources: EU General Data Protection Regulation 2016/679

Review the spoken promotion

Editorial recommendation

Assess the host-read wording and audible identification within the recording. Do not assume listeners will open show notes. Decide whether a filmed or broadcast version needs a separate review.

Campaign workflow

Prescription Medicines: prepare the review

Editorial recommendation

Identify the exact authorised medicine and prescription status. Resolve the public-promotion restriction or permitted route before developing creative. Separate medicine promotion from neutral disease information and healthcare-service advertising.

Keep a traceable campaign decision

Editorial recommendation

Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.

Pre-publication checklist

  • Identify the exact authorised medicine and prescription status.
  • Resolve the public-promotion restriction or permitted route before developing creative.
  • Separate medicine promotion from neutral disease information and healthcare-service advertising.
  • Record product or provider eligibility before approving claims.
  • Archive the final creative and its evidence, permissions and review decisions.
  • Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.

Scope and unresolved questions

  • Retained IVD advertising rules, Madrid device-ad approval and provider registration-number requirements are documented. Determine the actual autonomous community before filing; other regional procedures, profession-specific codes and the exact promotion remain to be checked.
  • This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates

Prescription-medicine advertising in podcasts and digital audio in Spain starts with a legal eligibility decision. Establish whether the proposed consumer message is permitted, restricted to limited information or confined to a professional route before developing benefit and risk statements.

Podcast listeners may hear a promotion without seeing its show notes. Assess audible commercial identification, the host's statements and required spoken information in the recording itself; a filmed podcast also needs a visual-format review.

Sources checked 2026-10-24 · Editorial research · Legal review pending

General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.

Coverage: National baseline and category-specific review routes; not an exhaustive compliance opinion

How to use this national baseline

Editorial overview

This framework combines researched national rules with editorial review steps. Spanish national health-advertising baseline plus EU requirements; autonomous-community rules remain relevant. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.

The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.

Your next step: choose a local partner

Use this framework to brief qualified local legal and regulatory specialists. Ask them to verify current requirements and assess your specific product, service and campaign before acting.

Sources

  1. RDL 1/2015: guarantees and rational use of medicines and health products

    Boletín Oficial del Estado · legislation · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  2. EU Unfair Commercial Practices Directive 2005/29/EC

    European Union · legislation · checked 2026-10-24

    EU framework implemented through national law; sector rules and local implementation also apply.

  3. LSSI: Publicidad en Internet

    Ministry for Digital Transformation · regulator guidance · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  4. EU General Data Protection Regulation 2016/679

    European Union · legislation · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

From framework to action

Local expertise in Spain

Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in Spain.

Medical & health marketing

No partners listed in this category yet.

Marketing & sales advisory

No partners listed in this category yet.

Business & project coordination

No partners listed in this category yet.

Browse partners in Spain

Join the local partner directory

Would you like your company to be listed?

Talk to us about the terms of a listing. Leave your details and we will get in touch.

Publicity@fdasm.com

Contact details for a partner listing enquiry

We use your details to respond to your enquiry and discuss a listing. Submitting the form does not automatically add your company to the directory. Read our Privacy & cookies policy. Privacy contact: Publicity@fdasm.com.